[Clinical features of extranodal malignant lymphoma--staging classification and treatment strategies].
Takagi
T
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008223:Lymphoma / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D011241:Prednisone / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy; D013964:Thyroid Neoplasms / Q000473:pathology / Q000628:therapy; D014067:Tonsillar Neoplasms / Q000473:pathology / Q000628:therapy; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone